Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
CEO | Dr. William V. Williams M.D. |
IPO Date | Feb. 24, 2021 |
Location | Canada |
Headquarters | Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1 |
Employees | 16 |
Sector | Healthcare |
Industry | Biotechnology |
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
NA
NA
StockViz Staff
September 19, 2024
Any question? Send us an email